解读RTOG 0617结果:识别与总生存相关的剂量敏感心脏亚区域
该研究基于RTOG 0617试验数据,采用基于体素的分析识别出心脏基底部为剂量与生存相关的显著区域(p < 0.001)。多变量Cox模型显示该区域剂量(p = 0.02)和肿瘤体积(p = 0.03)与生存显著相关,而放疗剂量水平不再显著(p = 0.07);倾向性评分匹配后不同放疗剂量水平间未见显著生存差异。作者认为高剂量组生存较差部分归因于心脏亚区域剂量,定义心脏避让区域可使未来剂量递增试验可行。
要点
- 心脏基底部剂量与总生存相关(p < 0.001),部分解释了高剂量组生存更差。
- 多变量Cox模型中心脏区域剂量(p = 0.02)和肿瘤体积(p = 0.03)与生存显著相关,放疗剂量水平不显著(p = 0.07)。
- 倾向性评分匹配后,不同放疗剂量水平间未见显著生存差异。
核心结论
- 心脏基底部剂量与总生存相关,部分消除了放疗剂量水平的影响,并解释高剂量组生存较差部分归因于心脏亚区域剂量。
- 作者认为,通过定义心脏避让区域,未来剂量递增试验可能可行。
研究设计与样本
- 基于RTOG 0617试验数据的二次分析,共458例患者符合基于体素分析的条件。
- 采用基于体素分析识别剂量与生存相关的解剖区域,并通过自举法将临床和剂量学变量纳入弹性网模型筛选与生存相关的变量。
- 使用多变量Cox回归评估心脏亚区域剂量与全心脏V5、V30对生存的影响,并对患者按肺剂量、心脏亚区域剂量和肿瘤体积进行倾向性评分匹配后评估试验结局。
主要发现
- 基于体素分析在心脏基底部识别出显著区域(p < 0.001)。
- 自举法筛选出平均肺剂量、放疗剂量水平、对数肿瘤体积和心脏区域剂量。
- 多变量Cox模型显示心脏区域剂量(p = 0.02)和肿瘤体积(p = 0.03)与生存显著相关,放疗剂量水平不显著(p = 0.07)。
- 模型显示全心脏V5和V30与生存无关,而放疗剂量水平显著(p < 0.05)。
- 在匹配队列中,不同放疗剂量水平间未见显著生存差异。
临床怎么用
- 作者认为,通过定义心脏避让区域,未来剂量递增试验可能可行。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The RTOG 0617 trial presented a worse survival for patients with lung cancer treated in the high-dose (74 Gy) arm. In multivariable models, radiation level and whole-heart volumetric dose parameters were associated with survival. In this work, we consider heart subregions to explain the observed survival difference between radiation levels. METHODS: Voxel-based analysis identified anatomical regions where the dose was associated with survival. Bootstrapping clinical and dosimetric variables into an elastic net model selected variables associated with survival. Multivariable Cox regression survival models assessed the significance of dose to the heart subregion, compared with whole heart v5 and v30. Finally, the trial outcome was assessed after propensity score matching of patients on lung dose, heart subregion dose, and tumor volume. RESULTS: A total of 458 patients were eligible for voxel-based analysis. A region of significance (p < 0.001) was identified in the base of the heart. Bootstrapping selected mean lung dose, radiation level, log tumor volume, and heart region dose. The multivariable Cox model exhibited dose to the heart region (p = 0.02), and tumor volume (p = 0.03) were significantly associated with survival, and radiation level was not significant (p = 0.07). The models exhibited that whole heart v5 and v30 were not associated with survival, with radiation level being significant (p < 0.05). In the matched cohort, no significant survival difference was seen between radiation levels. CONCLUSIONS: Dose to the base of the heart is associated with overall survival, partly removing the radiation level effect, and explaining that worse survival in the high-dose arm is owing, in part, to the heart subregion dose. By defining a heart avoidance region, future dose escalation trials may be feasible.
引用
- McWilliam A, Abravan A, Banfill K, et al. Demystifying the Results of RTOG 0617: Identification of Dose Sensitive Cardiac Subregions Associated With Overall Survival. J Thorac Oncol. 2023. PMID: 36738929. doi:10.1016/j.jtho.2023.01.085
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。